Question:

One of the objectives of AXMEDIS is to reduce the cost of content creation and distribution. Although this may provide a long-term increase in the profit margin available to content owners, distributors and retailers, it is at the expense of what could possibly be a significant technology investment and carries a high risk of arriving too late to market.

Answer:

This is not true. Since AXMEDIS provides the reduction in the automatisation of content production, protection and distribution disregarding the content formatting and DRM. The reduction of costs and the automatisation is obtained by using the AXCP that is not constrained to the MPEG-21 technology and that is not constrained to provide huge investment. The AXMEDIS AXCP is a ready to use technology with a very low investment for its exploitation.